9 février 2018
Embracing the insurance opportunities offered by digital technology, SCOR Global Life partners with Vivametrica to develop a new risk model based on data from wearable devices.
9 février 2018
Embracing the insurance opportunities offered by digital technology, SCOR Global Life partners with Vivametrica to develop a new risk model based on data from wearable devices.
SCOR annonce la finalisation de l’augmentation de sa participation dans MutRé S.A. à 100%
SCOR annonce la finalisation de l’augmentation de sa participation dans MutRé S.A. à 100%.
11 décembre 2017
In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
6 décembre 2017
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add
Presentation of Daria Ossipova about “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Annual Conference SCOR.
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
Paolo De Martin's presentation at the Pacific Insurance Conference 2017
4 décembre 2017
SCOR is driven to see its clients succeed and puts all its passion and energy into unlocking value for them.
30 novembre 2017
Antimicrobial resistance is a global concern that can jeopardize the treatment of infectious diseases.
Pagination